iPremom offers MaiRa, a clinician-prescribed prenatal blood test that estimates a pregnant woman’s risk of preeclampsia from week 9. It analyzes cell-free RNA in maternal blood with a proprietary predictive algorithm, giving obstetric teams an early risk report to guide monitoring and preventive decisions; it is a risk-assessment tool, not a diagnostic test.
AC
Amadeus Capital Partners
Activity from announced rounds
All recorded activity
- Rounds participated in
- 6
- Confirmed lead rounds
- 1 4 roles undisclosed
- New companies
- 6 First participation on record · 0 follow-on
- Funding in participating rounds
- $169.3M 6 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
6 in all activityiPremom
€15MSeed
LeadiPRONICS
iPRONICS builds silicon-photonics optical circuit switches that let AI data centers reconfigure high-bandwidth connections between compute systems across and within racks.
$125MSeries B
ParticipantRespiro Diagnostics
Develops breath-based diagnostic platform for lung cancer and respiratory diseases
£1MPre-Seed
Role not disclosedSlamcore
Provides visual AI software using stereo cameras to track vehicle position and behavior in factories and warehouses
$14MUndisclosed
Role not disclosedStateful Robotics
Equips robots with a continuous intelligence layer for operating in changing real-world environments
$4.8MPre-Seed
Role not disclosedRefute
AI-powered platform to detect and respond to disinformation and hybrid threats
£5MSeed
Role not disclosed